Streptococcus pneumoniae vaccination in older adults
Elizabeth Rightmier1, Vanessa Stevens, Jack Brown
1Department of Pharmacy, University of Rochester Medical Center, New York, USA.
The American Journal of Geriatric Pharmacotherapy
|November 4, 2011
Summary
Pneumococcal vaccination in older adults shows potential benefits despite conflicting efficacy data. Further research is needed to confirm the effectiveness of Streptococcus pneumoniae vaccines in this population.
Area of Science:
- Gerontology
- Infectious Diseases
- Vaccinology
Background:
- Streptococcus pneumoniae infections pose significant risks for older adults, contributing to morbidity and mortality.
- Existing vaccination strategies aim to prevent pneumococcal infections, but their efficacy in the elderly population remains under-researched.
Purpose of the Study:
- To systematically review existing literature on the efficacy and tolerability of Streptococcus pneumoniae vaccination in individuals aged 55 and older.
- To synthesize current evidence regarding pneumococcal vaccine effectiveness and safety in older and elderly adults.
Main Methods:
- Comprehensive literature search of PubMed and EMBASE databases (1950-present and 1974-present, respectively).
- Inclusion of randomized controlled trials and observational studies reporting on pneumococcal epidemiology, vaccine coverage, recommendations, tolerability, and efficacy/effectiveness in adults aged 55+.
- Identification of additional studies through reference list reviews.
Main Results:
- Review of six randomized controlled trials and 18 observational studies yielded conflicting findings on pneumococcal vaccine efficacy in older adults.
- Efficacy, assessed by clinical outcomes and immunogenicity, showed mixed results: some prospective studies indicated limited benefit, while retrospective studies suggested significant advantages.
- Discrepancies in results may stem from the limited statistical power of prospective subanalyses to detect significant differences.
Conclusions:
- Pneumococcal vaccination is likely warranted for older adults due to potential clinical benefits and a low incidence of serious adverse events.
- Further high-quality, prospective, well-controlled studies are essential to quantitatively assess the true benefit of pneumococcal vaccines in the elderly population.
More Related Videos
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...